AstraZeneca rumored to be mulling Forest bid

Forest Laboratories Inc. (NYSE:FRX) declined to comment on rumors that it is in talks to be acquired by AstraZeneca plc (LSE:AZN; NYSE:AZN). According to the Financial Times, talks between the companies may already have stalled because of Forest's recent stock spike. The company's shares are up about 30% since early October, including a jump of $5.01 (10%) to $56.32 on Monday after Forest unveiled a restructuring (see BioCentury Extra, Dec. 2). ...